Skip to content
    Deerfield Management Company logo

    Deerfield Management Company

    New York, New York, United StatesFounded 1994

    Deerfield Management Company is an investment firm focused on advancing healthcare through investments in therapeutics, medical devices, healthcare services, diagnostics, and digital health. They invest across all stages of a company's lifecycle, from early-stage startups to mature public companies, and employ a strategy that combines scientific rigor, operational support, and capital access to accelerate breakthrough solutions in the healthcare and life sciences sectors.Deerfield Management Company is an investment firm dedicated to advancing healthcare by investing across the entire healthcare ecosystem, including therapeutics, medical devices, healthcare services, diagnostics, and digital health. Their strategy involves providing capital, scientific expertise, and operational support to companies at all stages, from early-stage startups to mature public companies, with a focus on fostering innovation and improving global health outcomes.

    58% of their portfolio is in Healthcare. Average disclosed round size is $83.7M (across 12 rounds with reported amounts).

    Find people at Deerfield Management Company on Goldilocks AI

    Portfolio

    12

    Fund Size

    $16.1B

    Top Stage

    Series B

    Last 12 Mo

    0

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    12 investments
    CompanyRoundAmountDate
    Lomond Therapeutics logoLomond TherapeuticsSeries B$44MNov 2024
    SSomatusSeries E$325MFeb 2022
    Lark Health logoLark HealthSeries D$100MOct 2021
    Springtide logoSpringtideSeries A$18.1MNov 2020
    Annexon, Inc. logoAnnexon, Inc.Series D$100MJul 2020
    SSomatusSeries C$64MJun 2020
    Meditrina, Inc. logoMeditrina, Inc.Series A$10MJun 2020
    Blade Therapeutics logoBlade TherapeuticsSeries B$45MJun 2016
    Lumos Pharma logoLumos PharmaSeries B$34MApr 2016
    Spark Therapeutics logoSpark TherapeuticsSeries B$72.8MMay 2014
    Practice Fusion logoPractice FusionSeries D$70MSep 2013
    SSema4Series C$121M

    Top Co-Investors

    OrbiMed2 shared
    Flare Capital Partners2 shared
    Longitude Capital2 shared
    BlackRock2 shared
    Torrey Pines Investment1 shared
    GIC1 shared
    Section 321 shared
    Oak HC/FT1 shared

    Last updated: 15 April 2026